logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Prabhakar Kondaji Jadhav

This inventor holds 27 USPTO granted patents, primarily in Integrin Inhibitors. Top assignees: The Dupont Merck Pharmaceutical Company, E.i. Dupont De Nemours and Company, Dupont Pharmaceuticals Company. Active years: 1989-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prabhakar Kondaji Jadhav. Retrieved from https://idiyas.com/inventor/prabhakar-kondaji-jadhav

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 403(Granted Patents)


Location History:

  • Newark, DE (US) (1989)
  • Wilmington, DE (US) (1992 - 2003)

Company Filing History:

goldMedal12 out of 206 
 
The Dupont Merck Pharmaceutical Company
 patents
silverMedal6 out of 16,339 
 
E.i. Dupont De Nemours and Company
 patents
bronzeMedal5 out of 106 
 
Dupont Pharmaceuticals Company
 patents
4. 3 out of 234 
 
Bristol-Myers Squibb Pharma Company
 patents
5. 1 out of 834,570 
Other
 patents

Years Active: 1989-2003

Loading Chart...
Areas of Expertise:
Integrin Antagonists
Retroviral Protease Inhibitors
Cyclic Carbonyls
Alkylating Agents
Biomolecule Immobilization
Spirocycle Inhibitors
Fibrinogen Receptor Antagonists
Surface Modification
Lipid A Analog
Cyclic Urea
Caprolactams
Fluorocarbon Surface
27 patents (USPTO):Explore Patents
1. 6503898 - Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors (2003-01-07),
2. 6489333 - Integrin antagonists (2002-12-03),
3. 6476226 - Isoxazoline fibrinogen receptor antagonists (2002-11-05),
4. 6455560 - Isoxazoline fibrinogen receptor antagonists (2002-09-24),
5. 6319937 - Isoxazoline fibrinogen receptor antagonists (2001-11-20),
6. 6303609 - Isoxazoline fibrinogen receptor antagonists (2001-10-16),
7. 6214834 - Integrin inhibitor prodrugs (2001-04-10),
8. 5877312 - Method for preparing alkylating agents for their use for alkylating (1999-03-02),
9. 5877170 - Substitute caprolactams and derivatives thereof useful for treatment of (1999-03-02),
10. 5811422 - Substituted cyclic carbonyls and derivatives thereof useful as (1998-09-22),
11. 5760029 - Spirocycle integrin inhibitors (1998-06-02),
12. 5760028 - Integrin receptor antagonists (1998-06-02),
13. 5710159 - Integrin receptor antagonists (1998-01-20),
14. 5683999 - Cyclic urea HIV protease inhibitors (1997-11-04),
15. 5663333 - Substituted 1,4-diazapine caprolactams useful for treatment of HIV (1997-09-02),

Title: The Innovative Journey of Prabhakar Kondaji Jadhav

Introduction:

Prabhakar Kondaji Jadhav, a visionary inventor based in Wilmington, DE, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Prabhakar Kondaji Jadhav holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices, showcasing his versatility and ingenuity.

Career Highlights:

With a career spanning over two decades, Prabhakar Kondaji Jadhav has worked with leading tech companies, research institutions, and universities, honing his skills and pushing the boundaries of technological advancement.

Collaborations:

Throughout his career, Prabhakar Kondaji Jadhav has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge sharing to drive progress in the tech industry.

Conclusion:

Prabhakar Kondaji Jadhav's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in the technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…